Pain：针灸可有效预防全身性复发和加重

记者从日前在京召开的2011年中医学国际上年会上获悉，首都医科大学另设北京中医养老院中医学该中心经临床研究课题证实，传统习俗的中医中医学疗法可有效预防偏腹痛的患上和再加。相关研究课题博士论文昨日登载在国际上著名医学期刊《咳嗽》上，成为中国人中国首篇登载于该杂志的临床研究课题博士论文。该文还被国际上知名医学生物学管理机构 Faculty of 1000 medicine（千名微生物学家）精选。

据理解，作为临床常见病之一，偏腹痛发病率高，且有害严重。现今，现状18岁~65岁青年人的偏腹痛患病率高达9.3%，且有逐年升高趋势。中医学治疗法腹痛在中国人已经有数千年的近代。北京中医养老院中医学该中心自2004年设立腹痛专家门诊，开展了基于“金针王香山”、国医大师贺普仁等多位著名中医学学家治痛经验的腹痛研究课题。

据该该中心主任王麟鹏介绍，该建设项目采取单盲、双精心设计、随机对照的基本上，在国内5家养老院的中医学科共应征140名无先兆偏腹痛患者，随机分为三组成员，分别为治疗法组成员（中医学加口服）和准确率（假针加氟桂利嗪）。三组成员患者每周中医学治疗法3次，每晚口服药物。结果显示，4时更，治疗法组成员偏腹痛的有效减轻率为59%，准确率为40%；治疗法组成员咳嗽日数平均值上升4.1天，准确率平均值上升1.9天。16时更，治疗法组成员有效减轻率为56%，准确率为37%；治疗法组成员咳嗽日数平均值上升 4.1天，准确率平均值上升2天。

研究课题人员据此认为，中医学可以作为偏腹痛的预防患上和再加的步骤，其治果也优于早先多国的相关研究课题。由于其研究课题步骤的引人注目和重要性，该博士论文还被国际上知名医学生物学管理机构“千名化学家”精选。（生物谷 Bioon.com）

doi:10.1016/j.pain.2011.04.006PMC:PMID:

Efficacy of acupuncture for migraine prophylaxis: A single-blinded, double-dummy, randomized controlled trial

Lin-Peng Wang,Xiao-Zhe Zhang,Jia Guo,Hui-Lin Liu,Yan Zhang,Cun-Zhi Liu,Jing-Hong Yi,Li-Ping Wang,Ji-Ping Zhao,Shan-Shan Li

Summary This multicenter, double-dummy trial suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks. Abstract Insufficient clinical trial data were ailable to prove the efficacy of acupuncture for migraine prophylaxis. A multicenter, double-dummy, single-blinded, randomized controlled clinical trial was conducted at the outpatient departments of acupuncture at 5 hospitals in China to evaluate the effectiveness of acupuncture. A total of 140 patients with migraine without aura were recruited and assigned randomly to 2 different groups: the acupuncture group treated with verum acupuncture plus placebo and the control group treated with sham acupuncture plus flunarizine. Treated by acupuncture 3 times per week and drugs every night, patients from both groups were evaluated at week 0 (baseline), week 4, and week 16. The primary outcome was measured by the proportion of responders (defined as the proportion of patients with a reduction of migraine days by at least 50%). The secondary outcome measures included the number of migraine days, visual ogue scale (VAS, 0 to 10cm) for pain, as well as the physical and mental component summary scores of the 36-item short-form health survey (SF-36). The patients in the acupuncture group had better responder rates and fewer migraine days compared with the control group (P.05). The results suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks, whereas no significantly differences were found between acupuncture and flunarizine in reduction of pain intensity and improvement of the quality of life.